Answers are grounded in this paper and cite their sources.
Objectives To investigate whether distal lung parenchymal abnormalities detected on dual-layer spectral CT (DLCT), quantified by iodine density (ID) and effective atomic number (Zeff), are associated with pulmonary arterial involvement in patients with lung cancer. Materials and methods This retrospective study included 61 patients with pathologically confirmed lung cancer who underwent contrast-enhanced DLCT between June 2024 and September 2025. Regions of interest (ROIs) were placed in the distal and contralateral lung parenchyma. Conventional CT attenuation, ID and Zeff were measured on arterial-phase spectral images. Pulmonary arterial involvement was determined by predefined CT criteria, including segmental luminal narrowing or truncation of the pulmonary artery. Associations of distal spectral CT parameters with tumor size, tumor location and pulmonary arterial involvement were evaluated using subgroup analyses and multivariable linear regression. Results Interobserver agreement was excellent (intraclass correlation coefficient, ICC range, 0.87–0.99). ID and Zeff were significantly lower in the distal than in the contralateral lung parenchyma (both p < 0.01), whereas conventional CT attenuation showed no significant difference (p > 0.05). Greater relative differences in ID and Zeff were observed in tumors ≥30 mm, central tumors, and cases with pulmonary arterial involvement (all p < 0.01). After adjustment for tumor size and location, pulmonary arterial involvement remained significantly associated with both spectral parameters. Conclusion Spectral CT may provide complementary quantitative information on distal lung changes associated with pulmonary arterial abnormalities beyond conventional CT assessment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: